Shilajit: Evidence-Based Guide to Benefits, Forms, Dosing, and Safety

Table of Contents

• Overview
• Chemical Composition
• Geological Formation and Traditional Grading
• Forms and Bioavailability
• Evidence for Benefits
• Recommended Dosing
• Safety and Side Effects
• Drug Interactions
• Geographic Sources and Quality Indicators
• Regulatory Status
• Summary and Bottom Line
• References

Overview

Shilajit is a black-brown, tar-like resinous substance — sometimes called "mineral pitch" or "moumiyo" — produced from the slow decomposition of plant material over centuries within mountain rocks [1][2]. It is found primarily in the Himalayan Mountains between India and Nepal, as well as in the Altai Mountains of Russia and Mongolia, the Caucasus, the Pamir Plateau, Tibet, Afghanistan, and the Andes of northern Chile [1][2][3]. The substance exudes from cracks and crevices in steep rock faces at altitudes between 1,000 and 5,000 meters, typically during hot summer months when rising temperatures soften the resin [2][3].

The term "shilajit" originates from Sanskrit, where "shila" means rock and "jit" means conqueror, translating to "conqueror of mountains" or "destroyer of weakness" [3]. It is also known by alternative names across cultures: "moumiyo" or "mumijo" in Russian traditions, "brag-zhun" (meaning "rock juice") in Tibetan medicine, and "salajeet" in Unani practice [3][4].

Shilajit has been used for millennia in traditional medicine systems, particularly Ayurveda, where it is classified as a premier rasayana (rejuvenating substance) believed to promote vitality and overall health [2][3]. Classical Ayurvedic texts including the Charaka Samhita and Sushruta Samhita describe it as a potent restorative remedy prescribed for conditions ranging from chronic fatigue and arthritis to diabetes, infertility, and cognitive disorders [3][4].

Despite wide-ranging health claims — including boosting testosterone levels and improving fertility in men, improving digestive and skin disorders, preventing Alzheimer's disease, lowering cholesterol or blood sugar, and boosting blood levels of CoQ10 or minerals — clinical evidence is very limited [1]. Most studies are small, short-term, and frequently industry-funded. Only a handful of randomized controlled trials exist, and most suffer from methodological limitations that prevent firm conclusions.

Although often promoted as a natural mineral source, a typical 200 mg dose contains only 2–3 mg total minerals, less than 1% of recommended daily requirements [2].

Chemical Composition

Shilajit is a chemically complex substance whose full composition remains incompletely understood, comprising hundreds of compounds with significant variability across samples [5]. Its primary components include:

• Humic substances (60–80% of organic matter): Fulvic acid, humic acid, and humins form the core matrix. Fulvic acid, a low-molecular-weight fraction, typically accounts for 15–25% of raw shilajit and is considered the principal bioactive compound responsible for many of shilajit's pharmacological effects [5][6]. Fulvic acid demonstrates high bioavailability due to its solubility across a wide pH range and acts as a carrier molecule that may enhance mineral and nutrient absorption [6]. Preliminary studies suggest fulvic acid has antioxidant and anti-inflammatory properties [1].
• Dibenzo-alpha-pyrones (DBPs, 0.2–0.3%): Bioactive compounds to which immunomodulatory and adaptogenic properties of shilajit have been attributed [1][7]. These are metabolites of fungi and other organic matter that may have antioxidant properties [8].
• Minerals (15–20% by weight): Over 85 trace elements including iron, calcium, magnesium, zinc, copper, potassium, and selenium in ionic, bioavailable forms [5][6]. However, a typical 200 mg dose amounts to only 2–3 mg total minerals, representing less than 1% of recommended daily requirements — so shilajit supplements are unlikely to contribute meaningful amounts of minerals despite frequent marketing claims [9].
• Non-humic organic compounds (15–20%): Including proteins (13–17%), amino acids (e.g. glycine and aspartic acid), fatty acids (4–4.5%), steroids (3.3–6.5%), carbohydrates (1.5–2%), and bioactive phenolics such as caffeic and gallic acids [5][6].

The ratios of these components vary significantly depending on geographic source, altitude, and local geology. For example, Himalayan shilajit from India's Kumaon region shows higher fulvic acid levels (up to 21.4%) compared to samples from Nepal (15.4%) or Pakistan (15.5%) [6].

Geological Formation and Traditional Grading

Shilajit forms through a prolonged biological and geological process involving the decomposition of plant matter in high-altitude mountainous environments. It originates from the gradual breakdown of certain plant species, such as Euphorbia royleana and Trifolium repens, along with bryophytes, which accumulate in rocky crevices and sedimentary layers [2][10]. This decomposition is driven by microbial action — including molds like Barbula, Fissidens, Minium, and Thuidium — which convert organic material into a humus-like resin over centuries to millennia [2][10].

The process occurs in distinct stages: initial burial of plant debris in sedimentary rock layers at altitudes above 1,000 meters, followed by anaerobic microbial decomposition that polymerizes the material into complex humic substances, geological compression that prevents full mineralization, and finally exudation through rock cracks during summer heat [2][10].

Traditional Ayurvedic Grading

In traditional Ayurvedic classification, shilajit is graded by color and associated metal ore, as described in the Charaka Samhita [3][4]:

• Gold (Sauvarna) grade: Red or pale, considered the highest and rarest, used primarily for rejuvenation therapy
• Silver (Rajat) grade: White or pale, linked to silver, used for nervous system and bone marrow conditions
• Copper (Tamra) grade: Blue-tinted, used for liver-related conditions
• Iron (Lauha) grade: Black or dark brown, the most common variety, used in general treatments

These grades stem from traditional observations. In contemporary markets, "gold grade" typically refers to shilajit harvested from extreme high altitudes with purportedly higher fulvic acid concentrations, though scientific evidence for altitude-based superiority remains limited [3].

Shilajit's earliest documented references appear in classical Ayurvedic literature dating to approximately the 3rd century BCE. Persian scholars later documented it — Avicenna (Ibn Sina) referenced it in his Canon of Medicine in the 11th century CE [4]. In Tibetan medicine, it entered the pharmacopoeia by the 8th century CE through the Rgyud-bzhi (Four Tantras) [3][4].

Forms and Bioavailability

Shilajit supplements are available in two primary forms that differ substantially in their fulvic acid concentration and processing:

Form	Fulvic Acid Content	Typical Dose	Key Characteristics
Purified Resin	~6–7%	300–2,000 mg	Thick, tar-like consistency. Most traditional form. Higher total dose needed due to lower fulvic acid concentration. May contain a broader spectrum of naturally occurring compounds [1].
Standardized Extract	~60–80%	200–500 mg	Capsules, tablets, or powder. Most common in clinical trials. Lower dose needed due to higher fulvic acid concentration. Better standardized for research and quality control [1].

Other Commercial Forms

• Capsules and tablets: Most popular commercial format due to convenience. Typically contain standardized extracts [2].
• Gummies: Growing in popularity, though other ingredients like pectin (which naturally contains calcium) may complicate dosing accuracy [1].
• Dry drops: Contain concentrated fulvic acid, marketed for enhanced mineral and nutrient uptake [2].
• Topical creams: Incorporated into some skincare products, though clinical evidence for transdermal absorption of shilajit's bioactive compounds is lacking [2].

Key Bioavailability Considerations

Fulvic acid as the principal carrier molecule. Fulvic acid's low molecular weight (700–2,000 Da) and high water solubility across a wide pH range contribute to its bioavailability [6][11]. It acts as a chelating agent that can bind minerals and other nutrients, potentially enhancing their absorption in the gastrointestinal tract.

Standardization variability. Most commercial products do not disclose their percentage of fulvic acid, making direct comparisons difficult [1]. Products standardized to a specific fulvic acid content — such as PrimaVie (Natreon Inc.) at >50% fulvic acids plus 10% free dibenzo-alpha-pyrones — provide more reliable dosing for both consumers and researchers [8][12].

Resin vs. extract potency. Because purified resin contains approximately 6–7% fulvic acid while extracts contain 60–80%, the effective dose of bioactive compounds can differ by roughly 10-fold between forms at the same milligram weight [1]. A 500 mg resin dose delivers approximately 30–35 mg of fulvic acid, whereas a 500 mg extract dose delivers approximately 300–400 mg of fulvic acid. Clinical trials typically use standardized extracts, making it difficult to extrapolate results directly to resin-form supplements.

Purification methods. Traditional Ayurvedic purification involves dissolving raw shilajit in herbal decoctions (such as Triphala Kwatha), filtering through cloth, and sun-drying or gentle heating [4][11]. Modern purification employs aqueous extraction, centrifugation, ethanol precipitation, activated carbon filtration for heavy metal removal, ion-exchange chromatography, and ultrafiltration. Standardized products are typically verified to contain at least 50–60% fulvic acid, assessed via spectrophotometric methods or HPLC, with heavy metal levels quantified via ICP-MS [2][11].

How to take shilajit. Shilajit should be taken with water, with or without food [1]. For resin form, a pea-sized amount (approximately 300–500 mg) dissolved in warm water or milk is the traditional method [4].

Evidence for Benefits

Shilajit has been promoted for a wide range of uses. However, clinical evidence is limited — most human studies are small (typically n < 100), short in duration (45–90 days, with one exception at 48 weeks), and frequently industry-funded. A 2024 systematic review of clinical trials emphasized the need for larger, independent studies to validate efficacy across diverse populations [13].

Testosterone and Male Fertility

Several small, company-funded studies suggest shilajit may increase testosterone levels and improve certain measures of fertility in men. However, higher quality studies are needed to confirm these findings.

Testosterone in healthy older men. A randomized, double-blind, placebo-controlled study among 54 healthy men aged 45–55 found that 250 mg of shilajit extract standardized to 50% fulvic acids (PrimaVie, Natreon Inc.) taken twice daily (500 mg total/day) for 90 days produced statistically significant increases compared to placebo (Pandit et al., Andrologia, 2016) [12]:

• Total testosterone: increased 20.45% (p < 0.05)
• Free testosterone: increased 19.14% (p < 0.05)
• Dehydroepiandrosterone sulfate (DHEAS): increased 31.35% (p < 0.05)

This is the best-designed study to date, though the sample size remains small and the study was funded by the extract manufacturer.

Testosterone and fertility in oligospermic men. A preliminary study in men with low sperm count found that 100 mg of the same shilajit extract (PrimaVie) taken twice daily (200 mg total/day) for 90 days increased total testosterone levels by 23.5%, total sperm count by 61.4%, and sperm motility by 12–17% (Biswas et al., Andrologia, 2010) [14]. However, as no control group was included, no real conclusion can be drawn from this study — the observed changes could be attributable to regression to the mean, placebo effect, or natural fluctuation.

Synthesis. Two small, industry-funded trials suggest a modest testosterone-boosting effect in men. The better-designed placebo-controlled study showed approximately 20% increases in both total and free testosterone at 500 mg/day of standardized extract over 90 days. These results require replication in larger, independently funded trials. The effect, if real, is modest compared to pharmaceutical testosterone therapy.

Energy, Physical Performance, and Fatigue

Fatigued muscular strength in recreationally active men. A randomized controlled trial examined 63 recreationally active men supplementing with 250 mg, 500 mg, or placebo daily for 8 weeks. Those taking 500 mg daily showed significantly reduced fatigue-induced declines in muscular strength — 9.1% decline versus 15.7–16.0% decline in the lower-dose and placebo groups (p < 0.05). The 500 mg group also had lower serum hydroxyproline levels, suggesting potential benefits for exercise recovery and reduced connective tissue breakdown (Keller et al., J Int Soc Sports Nutr, 2019) [15]. Notably, the 250 mg dose did not produce statistically significant benefits over placebo, suggesting a dose-response relationship.

Open-label pilot study. A 2026 open-label pilot study in healthy adults taking 500 mg/day for 28 days reported improvements in multiple measures [16]:

• Muscle strength: +12.94% (leg press 1RM)
• Lean mass: +1.5%
• Fatigue reduction: −32.4%

However, as an open-label study without a placebo control, these results should be interpreted with extreme caution. The placebo effect, natural performance variation, and expectation bias can readily account for changes of this magnitude, particularly for subjective outcomes like fatigue.

Proposed mechanism. The proposed mechanism involves fulvic acid facilitating mitochondrial electron transport, thereby supporting ATP synthesis and reducing fatigue. Shilajit's dibenzo-alpha-pyrones may act as mitochondria-targeted antioxidants, potentially improving metabolic efficiency and preventing exercise-induced oxidative damage [10][16].

Synthesis. Limited evidence suggests 500 mg/day of shilajit extract may modestly reduce exercise-induced fatigue and support recovery. The one placebo-controlled trial showed a meaningful reduction in strength loss after fatiguing exercise at the 500 mg dose but not at 250 mg. The open-label pilot study results should not be over-interpreted due to lack of blinding and control.

Cholesterol and Lipid Profiles

A single small study in India among 30 healthy young adults (average age 24) examined the effects of 2 grams of shilajit resin (6.61% fulvic acid) daily for 45 days on blood lipids (Sharma et al., Anc Sci Life, 2003) [17]:

• Triglycerides: reduced from 116.9 to 92.7 mg/dL (20.7% decrease)
• Total cholesterol: reduced from 145.3 to 125.1 mg/dL (13.9% decrease)
• LDL cholesterol: reduced from 81.8 to 63.3 mg/dL (22.6% decrease)
• VLDL cholesterol: reduced from 23.3 to 18.5 mg/dL (20.6% decrease)
• HDL cholesterol: increased from 41.2 to 43.6 mg/dL (5.8% increase)

The placebo group showed no improvements. However, it is unclear if between-group differences were statistically significant — only within-group changes from baseline were reported as significant [1][17]. Additional limitations include the small sample size (n=30), a young and healthy population with already-normal lipid levels, the high dose of resin used (2 g/day), and the short duration (45 days). No other clinical trials have examined shilajit's effects on cholesterol, making it impossible to draw reliable conclusions about its lipid-lowering potential.

Blood Sugar and Diabetes

Evidence for shilajit's effects on blood sugar is mixed and inconclusive.

Modest blood sugar reduction. The preliminary study in oligospermic men found that 200 mg/day of shilajit standardized extract for 90 days slightly lowered average fasting blood sugar from 95.7 to 89.1 mg/dL (Biswas et al., Andrologia, 2010) [14]. However, this was not the primary outcome of the study, and there was no control comparison for this specific measure.

No effect with resin. The cholesterol study showed that 2 grams of shilajit resin daily for 45 days did not significantly affect blood sugar levels compared to baseline (Sharma et al., Anc Sci Life, 2003) [17].

Animal data. In diabetic mouse models, shilajit at 100 mg/kg daily restored glycemic control by lowering serum glucose and improving insulin sensitivity, potentially via antioxidant protection of pancreatic beta cells [18]. These findings have not been replicated in well-designed human trials.

Synthesis. Results are contradictory — a modest reduction in one uncontrolled study and no effect in another. Despite traditional use for diabetes, shilajit cannot be recommended for blood sugar management based on current evidence.

Collagen Production and Bone Health

Three studies, all involving the PrimaVie extract (Natreon Inc.), have examined shilajit's effects on collagen synthesis and bone density.

Collagen gene expression. A preliminary study found that shilajit supplementation increased gene expression of type I and type II collagen — the principal types found in tendons, bone, and skin (Das et al., J Med Food, 2016) [19]. While gene expression changes are mechanistically interesting, they do not necessarily translate into measurable clinical improvements.

Collagen synthesis biomarker. A subsequent study found that shilajit supplementation increased blood levels of pro-c1a1, a biomarker of type 1 collagen synthesis (Neltner et al., J Diet Suppl, 2024) [20]. Whether this translates into functional clinical improvements was not determined.

Bone mineral density in postmenopausal women with osteopenia. The most robust and longest study of shilajit is a randomized, double-blind, placebo-controlled trial among 59 postmenopausal women (average age 56) in India with mild to moderate osteopenia. Participants took either 250 mg or 500 mg of shilajit extract (PrimaVie, standardized to >50% fulvic acids plus 10% free dibenzo-alpha-pyrones) daily, or placebo, for 48 weeks (approximately 11 months) (Pingali et al., Phytomedicine, 2022) [8]:

• The 500 mg/day group had a small but statistically significant increase in lumbar spine bone mineral density (BMD) of approximately 1%, compared to an approximately 4% decrease in the placebo group.
• The 500 mg/day group did NOT increase BMD at the femoral neck (hip).
• The 250 mg/day group did not lose bone density in the lumbar spine or femoral neck, but also did not achieve a statistically significant increase in lumbar spine BMD compared to placebo.
• Significant reductions were observed in markers of bone turnover: CTX-1 (bone resorption marker) decreased, BALP (bone formation marker) normalized, RANKL decreased, and osteoprotegerin (OPG) increased in the treatment groups.
• Oxidative stress markers improved: lower MDA (malondialdehyde), higher GSH (glutathione).
• Inflammation markers improved: lower hsCRP (high-sensitivity C-reactive protein).
• No serious adverse events were reported over the 48-week period.

This is the longest published human trial of shilajit supplementation. Important caveats apply: dietary calcium intake was not reported, and calcium intake among women in India has been reported to be less than recommended levels, so it is unclear whether shilajit would provide the same benefit in women with adequate calcium intake. Natreon Inc. supplied the shilajit extract but reportedly did not provide funding for the study [1][8].

CoQ10 Enhancement

Animal studies and one unpublished pilot study in six people suggest shilajit may increase levels of CoQ10 in the body (Stohs, Phytother Res, 2014) [9]. The proposed mechanism involves dibenzo-alpha-pyrones acting as electron carriers that may support CoQ10 recycling in mitochondria [10]. However, the human evidence consists of a single unpublished pilot study with only six subjects — far too small to draw any conclusions. More rigorous clinical evidence is needed [9].

Cognitive Function and Alzheimer's Disease

Tau protein aggregation (in vitro). Laboratory research suggests that fulvic acid and other constituents of shilajit can block the aggregation of tau proteins, a key pathological hallmark of Alzheimer's disease. A 2023 study examining Andean shilajit fractions found dose-dependent inhibition of tau self-aggregation in vitro, with specific dibenzo-alpha-pyrones identified as active components that preserved neuronal viability (Andrade et al., Pharmaceuticals, 2023) [21].

Animal models. Preclinical studies in rodent models have demonstrated potential memory enhancement through reduced amyloid-beta-induced neurotoxicity, enhanced cerebral blood flow, and nitric oxide regulation [22][23]. These studies support a mechanistic rationale for cognitive benefits but do not demonstrate clinical efficacy.

No human clinical trials. Despite promising in vitro and animal data, there do not appear to be any clinical studies of shilajit for Alzheimer's disease prevention or treatment in humans [1][21]. The gap between laboratory findings and clinical application remains completely unbridged.

Synthesis. The mechanistic rationale is interesting from a basic science perspective, but the complete absence of human clinical data means shilajit cannot be recommended for cognitive health or Alzheimer's prevention. Laboratory and animal findings frequently fail to translate into clinical benefits.

Antioxidant and Anti-inflammatory Effects

In vitro studies demonstrate that fulvic acid from shilajit reduces oxidative stress by activating the Nrf2/HO-1 pathway and suppressing NF-kB-mediated inflammation [10][24]. Shilajit extracts exhibit dose-dependent free radical scavenging in cell cultures, comparable to standard antioxidants like ascorbic acid [24].

However, in vitro antioxidant activity is a notoriously poor predictor of clinical benefit. The only human data on shilajit's antioxidant effects come as secondary outcomes from other trials: the bone density trial showed reduced oxidative stress markers (lower MDA, higher GSH) [8], and the fertility study reported improved antioxidant status [14]. These are secondary findings from small trials and do not constitute standalone evidence for clinically meaningful antioxidant benefits.

Immune Modulation

Preclinical studies suggest shilajit may activate complement pathways and enhance phagocytic activity in vitro, promoting immune cell activation in a balanced manner without overactivation [18][25]. These immune-modulating effects have been attributed to shilajit's antioxidant properties and its ability to stimulate immune cells in preclinical models.

However, these findings are from cell culture and animal models only. There are no robust clinical trials specifically supporting claims for immunity enhancement [2].

Mitochondrial Function

Shilajit's components, particularly dibenzo-alpha-pyrones, act as mitochondria-targeted antioxidants in preclinical models, potentially preventing mitochondrial dysfunction and oxidative damage [18]. Fulvic acid's role as an electron carrier may support mitochondrial electron transport chain function and ATP production [10].

These mechanisms are consistent with shilajit's traditional classification as a rasayana in Ayurveda. However, mitochondrial claims remain entirely preclinical — no human studies have evaluated shilajit specifically for aging biomarkers, and the translation from mitochondrial mechanisms to measurable benefits in humans is speculative.

Recommended Dosing

Due to the low quality of evidence from clinical trials, there is insufficient information to recommend a dose of shilajit for any specific health condition, or to say how long it might take to work [1]. The doses below are drawn from published studies but should not be interpreted as established therapeutic doses.

Indication	Dose Used	Form	Duration	Study Design	Reference
Testosterone (healthy men 45–55)	250 mg twice daily (500 mg/day)	Standardized extract (50% fulvic acids)	90 days	RCT, placebo-controlled, n=54	Pandit 2016 [12]
Fertility (oligospermic men)	100 mg twice daily (200 mg/day)	Standardized extract (50% fulvic acids)	90 days	Uncontrolled, n=28	Biswas 2010 [14]
Exercise recovery	500 mg/day	Shilajit supplement	8 weeks	RCT, n=63	Keller 2019 [15]
Cholesterol reduction	2,000 mg/day (2 g)	Purified resin (6.61% fulvic acid)	45 days	RCT, n=30	Sharma 2003 [17]
Bone density (postmenopausal)	250 mg or 500 mg/day	Standardized extract (>50% fulvic acids)	48 weeks	RCT, placebo-controlled, n=59	Pingali 2022 [8]
Physical performance (pilot)	500 mg/day	Standardized extract	28 days	Open-label, uncontrolled	2026 pilot [16]

General Dosing Guidance

• Standardized extracts (50–80% fulvic acid): 200–500 mg per day. Most clinical trials used 200–500 mg/day of standardized extract.
• Purified resin (6–7% fulvic acid): The one study using resin employed 2,000 mg/day [17]. Due to the lower fulvic acid concentration, much higher doses of resin are needed to approximate the bioactive content of standardized extracts.
• Duration: Most studies administered shilajit for 45–90 days. The longest trial lasted 48 weeks [8].
• Dose-response relationship: The exercise study found that 500 mg/day was effective while 250 mg/day was not significantly different from placebo [15], suggesting a minimum effective dose may exist at least for some outcomes.

Practical Notes

• Shilajit should be taken with water, with or without food [1].
• No study has established a maximum safe dose, though doses up to 2,000 mg/day of resin and 500 mg/day of standardized extract have been used without reported adverse effects [8][17].
• Product quality varies enormously. Look for products that disclose fulvic acid percentage and provide third-party testing certificates for heavy metals (lead, arsenic, mercury, thallium) [2][26].
• Without knowing the fulvic acid content, it is impossible to match the doses used in clinical studies.

Safety and Side Effects

General Tolerability

Shilajit appears to be well tolerated in most adults when taken in daily doses of up to 2,000 mg (2 grams) of resin or 500 mg of standardized extract, with no side effects reported in published clinical studies (Biswas, Andrologia, 2010; Sharma, Anc Sci Life, 2003) [1][14][17]. The longest clinical trial (48 weeks at up to 500 mg/day of standardized extract) reported no serious adverse events (Pingali, Phytomedicine, 2022) [8].

However, several important caveats apply: most studies have been small (typically n < 100) and short (45–90 days), with limited statistical power to detect uncommon adverse effects. Long-term safety data beyond 48 weeks does not exist in published human studies. Systematic reviews and experts highlight the need for larger, longer-term trials to assess risks such as cumulative trace heavy metal exposure even in purified forms [2][13].

Potential Side Effects

Reported or potential side effects include [2][26]:

• Headache — occasionally reported in post-market surveillance
• Gastrointestinal upset — nausea, diarrhea, or stomach pain in some individuals
• Allergic reactions — rare, but may manifest as skin rashes, itching, or digestive discomfort in sensitive individuals

Heavy Metal Contamination

This is the primary safety concern with shilajit supplements. Raw, unprocessed shilajit frequently contains contaminants including heavy metals such as lead, arsenic, mercury, and thallium [26][27].

• A 2025 study published in BMC Chemistry identified elevated thallium levels in several commercial shilajit supplements, highlighting that contamination risk persists even in products marketed as "purified" [27].
• The WHO and FDA emphasize the importance of testing and purification to minimize heavy metal contaminants in dietary supplements [26].
• Raw or minimally processed shilajit carries the highest contamination risk and should never be consumed without proper purification.
• Third-party laboratory testing via ICP-MS for heavy metals (lead, arsenic, mercury, thallium, cadmium) should be verified before purchasing any shilajit product. Compliance with Prop 65 limits or similar standards is a reasonable baseline [2].

Blood Sugar Concerns

Although evidence is mixed, animal studies and one small study in men suggest that shilajit has the potential to lower blood sugar. It should be used with caution in people with low blood sugar levels (hypoglycemia) or those who take blood sugar-lowering medications, as it could potentiate glucose-lowering effects and increase the risk of hypoglycemia (Biswas, Andrologia, 2010; Stohs, Phytother Res, 2014) [1][9][14].

Populations That Should Avoid Shilajit

• Children: No safety data exists [1].
• Pregnant or breastfeeding women: Should avoid shilajit due to insufficient reliable evidence of safety in these populations [1][2].
• People with hemochromatosis or iron overload conditions: Shilajit contains iron and other minerals that could potentially worsen iron overload.
• People with kidney disease: The mineral and heavy metal content could be problematic for those with impaired renal clearance.

Drug Interactions

Drug Class	Examples	Interaction Risk	Clinical Implication
Diabetes medications	Insulin, metformin, sulfonylureas, SGLT2 inhibitors	Moderate	Shilajit may lower blood glucose and potentiate the effects of antidiabetic drugs, potentially causing hypoglycemia. Monitor blood sugar closely if combining [1][2][9].
Anticoagulants/blood thinners	Warfarin, heparin	Theoretical	Shilajit's effects on iron metabolism and mineral chelation could theoretically interact with anticoagulant therapy. No documented interactions, but caution is warranted.
Immunosuppressants	Cyclosporine, tacrolimus	Theoretical	Preclinical data suggests immunomodulatory effects. Theoretical risk of interference with immunosuppressive therapy [2].

Drug absorption considerations. As a rich source of humic and fulvic acids with strong chelating properties, shilajit has the theoretical potential to bind medications in the gastrointestinal tract and alter their absorption, similar to how mineral supplements interact with certain antibiotics (tetracyclines, fluoroquinolones), bisphosphonates, and levothyroxine. While this specific interaction has not been studied for shilajit, it is prudent to separate shilajit from medications by at least 2 hours as a precautionary measure.

No documented interactions exist between shilajit and testosterone replacement therapy (TRT), Adderall (amphetamine/dextroamphetamine), or bupropion in published literature [2]. The absence of documented interactions does not guarantee safety — it likely reflects a lack of systematic study rather than proven compatibility.

Given the limited drug interaction data, anyone taking prescription medications should consult their healthcare provider before starting shilajit supplementation. This is particularly important for those taking blood sugar-lowering drugs, blood thinners, or immunosuppressants [1][2].

Geographic Sources and Quality Indicators

Shilajit is not a food ingredient and has no dietary sources. It is a geological substance formed over centuries from decomposed plant material and microbial action, and can only be obtained from mountain rock deposits or as a manufactured supplement [2][3].

Primary Geographic Sources

• Himalayan Mountains — India (Arunachal Pradesh to Kashmir), Nepal, Bhutan. The most documented and valued source [3].
• Altai Mountains — Russia, Mongolia. Altai mumijo tends to be drier and denser in mineral content than Himalayan varieties [3].
• Central Asian ranges — Pamir Plateau, Hindu Kush, Ural Mountains [2][3].
• Tibetan Plateau — Tibet, China [2].
• Caucasus region — Georgia, Armenia, Azerbaijan [2].

Seasonal Harvesting

Collection occurs seasonally, primarily during summer months (June–September in the Himalayas) when rising temperatures cause the substance to soften and exude from rock fissures [3]. The process is labor-intensive and hazardous — deposits are located in remote, high-altitude terrains (1,000–5,000 meters) on steep slopes with inclinations of 60 degrees or more [3].

Quality Indicators for Consumers

• Fulvic acid content disclosure: Premium purified resin contains 6–20% fulvic acid; standardized extracts contain 50–80% [1][3]. Products that do not disclose fulvic acid percentage make it impossible to assess potency.
• Third-party heavy metal testing: Essential. Look for certificates of analysis showing lead, arsenic, mercury, and thallium levels below established safety thresholds [2][27].
• Source disclosure: Himalayan and Altai sources are the most documented in scientific literature.
• Solubility test: High-quality shilajit dissolves nearly completely in warm water with minimal residue [3].
• Physical characteristics (resin form): Glossy, tacky at room temperature, hardens when cooled, earthy or coniferous aroma [3].

Regulatory Status

United States

In the United States, purified shilajit is regulated as a new dietary ingredient under the Dietary Supplement Health and Education Act (DSHEA) of 1994, requiring premarket notifications to the FDA. Manufacturers must ensure safety and accurate labeling but are not required to obtain pre-market FDA approval for efficacy claims. Shilajit does not hold Generally Recognized as Safe (GRAS) status but is permitted in dietary supplements if compliant with current good manufacturing practices [2][26].

European Union

In the EU, shilajit remains unapproved as a novel food under Regulation (EU) 2015/2283, subjecting it to strict premarket authorization requirements by the European Food Safety Authority (EFSA). As of 2025, no approvals have been confirmed for shilajit as a novel food ingredient [2]. This means shilajit-containing supplements may face legal restrictions in EU member states.

India

The Ministry of AYUSH enforces standards for shilajit authenticity through the Ayurvedic Pharmacopoeia, mandating tests for solubility, fulvic acid content (>40%), and heavy metal limits (<1 ppm), along with certificates of analysis for commercial products [4].

Summary and Bottom Line

Shilajit is a complex geological substance with a long history in traditional medicine, particularly Ayurveda. While it contains potentially bioactive compounds — primarily fulvic acid and dibenzo-alpha-pyrones — the clinical evidence for most health claims remains preliminary at best.

What has some evidence (but needs more research):

• Modest testosterone increases in older men (one small RCT, 500 mg/day standardized extract for 90 days) [12]
• Attenuation of bone loss in postmenopausal women with osteopenia (one RCT, 500 mg/day for 48 weeks) [8]
• Reduced exercise-induced fatigue (one RCT, 500 mg/day for 8 weeks) [15]

What lacks convincing human evidence:

• Cholesterol reduction (one small study with unclear between-group statistics) [17]
• Blood sugar control (mixed results, no definitive trial) [14][17]
• CoQ10 enhancement (one unpublished pilot in 6 people) [9]
• Cognitive function or Alzheimer's prevention (in vitro and animal data only) [21]
• Mitochondrial or immune health (preclinical only) [18][25]

Safety: Well-tolerated in clinical trials at up to 500 mg/day for 48 weeks and 2 g/day for 45 days, but heavy metal contamination in poorly processed products is a real and documented risk. Third-party testing is essential [27].

References

1. ConsumerLab. "Shilajit Supplements Review." Accessed 2026. https://www.consumerlab.com/reviews/shilajit/shilajit-supplements/
2. Grokipedia. "Shilajit." https://grokipedia.com/page/Shilajit
3. Grokipedia. "Shilajit — Geographical Distribution and Varieties." https://grokipedia.com/page/Shilajit
4. Grokipedia. "Shilajit — Historical and Cultural Context." https://grokipedia.com/page/Shilajit
5. Grokipedia. "Shilajit — Chemical Composition: Primary Components." https://grokipedia.com/page/Shilajit
6. Wilson E, et al. "Review on shilajit used in traditional Indian medicine." J Ethnopharmacol. 2011;136(1):1-9.
7. Islam A. "Pilot toxicity study and anti-inflammatory effect of shilajit." Electronic J Biotech. 2008.
8. Pingali U, et al. "Effect of standardized shilajit extract on bone mineral density in postmenopausal women with osteopenia: A randomized, double-blind, placebo-controlled trial." Phytomedicine. 2022.
9. Stohs SJ. "Safety and efficacy of shilajit (mumie, moomiyo)." Phytother Res. 2014;28(4):475-479.
10. Grokipedia. "Shilajit — Scientific Research: Antioxidant and Mitochondrial Mechanisms." https://grokipedia.com/page/Shilajit
11. Grokipedia. "Shilajit — Chemical Composition: Purification Methods." https://grokipedia.com/page/Shilajit
12. Pandit S, Biswas S, Jana U, et al. "Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers." Andrologia. 2016;48(5):570-575.
13. Grokipedia. "Shilajit — Clinical Evidence and Limitations: 2024 Systematic Review." https://grokipedia.com/page/Shilajit
14. Biswas TK, Pandit S, Mondal S, et al. "Clinical evaluation of spermatogenic activity of processed Shilajit in oligospermia." Andrologia. 2010;42(1):48-56.
15. Keller JL, et al. "The effects of shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels." J Int Soc Sports Nutr. 2019.
16. Grokipedia. "Shilajit — 2026 Open-label Pilot Study." https://grokipedia.com/page/Shilajit
17. Sharma P, Jha J, Shrinivas V, et al. "Shilajit: evaluation of its effects on blood chemistry of normal human subjects." Anc Sci Life. 2003;23(2):114-119.
18. Grokipedia. "Shilajit — Antidiabetic, Anti-aging, and Immune Modulation Studies." https://grokipedia.com/page/Shilajit
19. Das A, et al. "The human skeletal muscle transcriptome in response to oral shilajit supplementation." J Med Food. 2016;19(7):701-709.
20. Neltner TJ, et al. "Effect of shilajit supplementation on type 1 collagen synthesis biomarker." J Diet Suppl. 2024.
21. Andrade V, et al. "Shilajit fractions inhibit tau self-aggregation and preserve neuronal viability." Pharmaceuticals. 2023.
22. Carrasco-Gallardo C, et al. "Shilajit: a natural phytocomplex with potential procognitive activity." Int J Alzheimers Dis. 2012.
23. Grokipedia. "Shilajit — Cognitive and Neurological Benefits: Preclinical Models." https://grokipedia.com/page/Shilajit
24. Grokipedia. "Shilajit — Antioxidant and Anti-inflammatory Effects: In Vitro Studies." https://grokipedia.com/page/Shilajit
25. Grokipedia. "Shilajit — Immune Modulation Studies." https://grokipedia.com/page/Shilajit
26. Grokipedia. "Shilajit — Safety Concerns and Regulations." https://grokipedia.com/page/Shilajit
27. BMC Chemistry. "Elevated thallium levels in commercial shilajit supplements." 2025.